154 related articles for article (PubMed ID: 1762378)
41. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients.
Robert JJ; Deschamps I; Chevenne D; Roger M; Mogenet A; Boitard C
Diabetes Care; 1991 Aug; 14(8):718-23. PubMed ID: 1954807
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology and immunogenetic background of islet cell antibody--positive nondiabetic schoolchildren. Ulm-Frankfurt population study.
Boehm BO; Manfras B; Seissler J; Schöffling K; Glück M; Holzberger G; Seidl S; Kühnl P; Trucco M; Scherbaum WA
Diabetes; 1991 Nov; 40(11):1435-9. PubMed ID: 1936604
[TBL] [Abstract][Full Text] [Related]
43. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.
Krischer JP; Cuthbertson DD; Yu L; Orban T; Maclaren N; Jackson R; Winter WE; Schatz DA; Palmer JP; Eisenbarth GS
J Clin Endocrinol Metab; 2003 Jan; 88(1):103-8. PubMed ID: 12519837
[TBL] [Abstract][Full Text] [Related]
44. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
Greenbaum CJ; Sears KL; Kahn SE; Palmer JP
Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
[TBL] [Abstract][Full Text] [Related]
45. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
46. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.
Keskinen P; Korhonen S; Kupila A; Veijola R; Erkkilä S; Savolainen H; Arvilommi P; Simell T; Ilonen J; Knip M; Simell O
Diabetologia; 2002 Dec; 45(12):1639-48. PubMed ID: 12488953
[TBL] [Abstract][Full Text] [Related]
47. Comparison of insulin autoantibodies in diabetes-related and healthy populations by precise displacement ELISA.
Dean BM; McNally JM; Bonifacio E; Jennings AM; Dunger DB; Gale EA; Bottazzo GF
Diabetes; 1989 Oct; 38(10):1275-81. PubMed ID: 2676657
[TBL] [Abstract][Full Text] [Related]
48. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Gianani R; Pugliese A; Bonner-Weir S; Shiffrin AJ; Soeldner JS; Erlich H; Awdeh Z; Alper CA; Jackson RA; Eisenbarth GS
Diabetes; 1992 Mar; 41(3):347-53. PubMed ID: 1551494
[TBL] [Abstract][Full Text] [Related]
49. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren.
Bergua M; Solé J; Marion G; Perez MC; Recasens A; Fernàndez J; Casamitjana R; Gomis R
Diabetologia; 1987 Sep; 30(9):724-6. PubMed ID: 3322914
[TBL] [Abstract][Full Text] [Related]
51. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
[TBL] [Abstract][Full Text] [Related]
52. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
Jennings AM; Spencer KM; Dean BM; Wilson RM; Bottazzo GF; Ward JD
Diabet Med; 1989 Jul; 6(5):434-9. PubMed ID: 2527682
[TBL] [Abstract][Full Text] [Related]
53. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
Gardner SG; Gale EA; Williams AJ; Gillespie KM; Lawrence KE; Bottazzo GF; Bingley PJ
Diabetes Care; 1999 Dec; 22(12):2049-54. PubMed ID: 10587841
[TBL] [Abstract][Full Text] [Related]
54. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.
Yu L; Cuthbertson DD; Maclaren N; Jackson R; Palmer JP; Orban T; Eisenbarth GS; Krischer JP;
Diabetes; 2001 Aug; 50(8):1735-40. PubMed ID: 11473032
[TBL] [Abstract][Full Text] [Related]
55. Autoantibodies to pancreatic islet cells and insulin in IDDM families: the GAW5 data.
Maclaren NK; Riley WJ; McCulloch DK; Palmer JP
Genet Epidemiol; 1989; 6(1):39-41. PubMed ID: 2659429
[TBL] [Abstract][Full Text] [Related]
56. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
57. Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins.
Johnston C; Millward BA; Hoskins P; Leslie RD; Bottazzo GF; Pyke DA
Diabetologia; 1989 Jun; 32(6):382-6. PubMed ID: 2668086
[TBL] [Abstract][Full Text] [Related]
58. [Islet-cell antibodies in juvenile diabetes mellitus (author's transl)].
Ludwig H; Schernthaner G; Mayr WR
Dtsch Med Wochenschr; 1977 Aug; 102(34):1221-4. PubMed ID: 334498
[TBL] [Abstract][Full Text] [Related]
59. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
Bergerot I; Souchier C; Thivolet C
C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
[TBL] [Abstract][Full Text] [Related]
60. Acute insulin response to glucose and glucagon in subjects at risk of developing type I diabetes.
Vialettes B; Zevaco-Mattei C; Thirion X; Lassmann-Vague V; Pieron H; Mercier P; Vague P
Diabetes Care; 1993 Jul; 16(7):973-7. PubMed ID: 8359105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
